Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tiago Torres

Showing results (91-100 of 274) with videos related to

Pageof 28
Sort By:
American Journal of Clinical Dermatology|August 11, 2020
Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and AbrocitinibSandra Ferreira, Emma Guttman-Yassky, Tiago Torres
Drugs|May 17, 2023
Baricitinib for the Treatment of Alopecia AreataEgídio Freitas, Emma Guttman-Yassky, Tiago Torres
Drugs in Context|August 12, 2024
New and emerging oral therapies for psoriasisOrhan Yilmaz, João Pedro Pinto, Tiago Torres
Drugs of Today (Barcelona, Spain : 1998)|June 7, 2022
Bimekizumab for psoriasisMaria Alexandra Rodrigues, Egídio Freitas, Tiago Torres
American Journal of Clinical Dermatology|August 12, 2022
Deucravacitinib for the Treatment of Psoriatic DiseaseAna Maria Lé, Luis Puig, Tiago Torres
Drug Design, Development and Therapy|March 17, 2021
An Overview of Bimekizumab for the Treatment of Psoriatic Arthritis: The Evidence so FarDaniel G Oliveira, Raquel Faria, Tiago Torres
The Journal of Dermatological Treatment|August 11, 2021
Baricitinib for the treatment of atopic dermatitisAmelia Melo, Jose Manuel Carrascosa, Tiago Torres
Ecotoxicology (London, England)|February 26, 2017
Methyl-triclosan and triclosan impact embryonic development of Danio rerio and Paracentrotus lividusSofia Macedo, Tiago Torres, Miguel M Santos
Drugs|October 4, 2024
Emerging Biologic Therapies for the Treatment of Atopic DermatitisJosé Miguel Alvarenga, Thomas Bieber, Tiago Torres
The Journal of Dermatological Treatment|December 1, 2022
Deucravacitinib in the treatment of psoriasisTomás Estevinho, Ana Maria Lé, Tiago Torres
Pageof 28

Showing results (91-100 of 274) with videos related to

Sort By:
Pageof 28
American Journal of Clinical Dermatology|August 11, 2020
Selective JAK1 Inhibitors for the Treatment of Atopic Dermatitis: Focus on Upadacitinib and AbrocitinibSandra Ferreira, Emma Guttman-Yassky, Tiago Torres
Drugs|May 17, 2023
Baricitinib for the Treatment of Alopecia AreataEgídio Freitas, Emma Guttman-Yassky, Tiago Torres
Drugs in Context|August 12, 2024
New and emerging oral therapies for psoriasisOrhan Yilmaz, João Pedro Pinto, Tiago Torres
Drugs of Today (Barcelona, Spain : 1998)|June 7, 2022
Bimekizumab for psoriasisMaria Alexandra Rodrigues, Egídio Freitas, Tiago Torres
American Journal of Clinical Dermatology|August 12, 2022
Deucravacitinib for the Treatment of Psoriatic DiseaseAna Maria Lé, Luis Puig, Tiago Torres
Drug Design, Development and Therapy|March 17, 2021
An Overview of Bimekizumab for the Treatment of Psoriatic Arthritis: The Evidence so FarDaniel G Oliveira, Raquel Faria, Tiago Torres
The Journal of Dermatological Treatment|August 11, 2021
Baricitinib for the treatment of atopic dermatitisAmelia Melo, Jose Manuel Carrascosa, Tiago Torres
Ecotoxicology (London, England)|February 26, 2017
Methyl-triclosan and triclosan impact embryonic development of Danio rerio and Paracentrotus lividusSofia Macedo, Tiago Torres, Miguel M Santos
Drugs|October 4, 2024
Emerging Biologic Therapies for the Treatment of Atopic DermatitisJosé Miguel Alvarenga, Thomas Bieber, Tiago Torres
The Journal of Dermatological Treatment|December 1, 2022
Deucravacitinib in the treatment of psoriasisTomás Estevinho, Ana Maria Lé, Tiago Torres
Pageof 28